These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 28577884)

  • 21. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
    Salvador S; Scott S; Francis JA; Agrawal A; Giede C
    J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Use of Opportunistic Salpingectomy at the Time of Benign Hysterectomy.
    Till SR; Kobernik EK; Kamdar NS; Edwards MG; As-Sanie S; Campbell DA; Morgan DM
    J Minim Invasive Gynecol; 2018 Jan; 25(1):53-61. PubMed ID: 28712794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postpartum Opportunistic Salpingectomy Compared With Bilateral Tubal Ligation After Vaginal Delivery for Ovarian Cancer Risk Reduction: A Cost-Effectiveness Analysis.
    Wagar MK; Forlines GL; Moellman N; Carlson A; Matthews M; Williams M
    Obstet Gynecol; 2023 Apr; 141(4):819-827. PubMed ID: 36897130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer: a systematic review.
    Darelius A; Lycke M; Kindblom JM; Kristjansdottir B; Sundfeldt K; Strandell A
    BJOG; 2017 May; 124(6):880-889. PubMed ID: 28190289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opportunistic Salpingectomy at the Time of Laparoscopic Cholecystectomy for Ovarian Cancer Prevention: A Cost-effectiveness Analysis.
    Matsuo K; Chen L; Matsuzaki S; Mandelbaum RS; Ciesielski KM; Silva JP; Klar M; Roman LD; Accordino MK; Melamed A; Elkin E; Hershman DL; Wright JD
    Ann Surg; 2023 May; 277(5):e1116-e1123. PubMed ID: 35129467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Opportunistic Salpingectomy for Permanent Contraception: A Cross Sectional Study in Portugal].
    São Pedro V; Pires R; Santos F; Tovim Rodrigues C; Santos Silva I; Almeida MC; Águas F
    Acta Med Port; 2021 Mar; 34(4):258-265. PubMed ID: 34214417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: A survey of current Australian practice.
    Kapurubandara S; Qin V; Gurram D; Anpalagan A; Merkur H; Hogg R; Brand A
    Aust N Z J Obstet Gynaecol; 2015 Dec; 55(6):606-11. PubMed ID: 26768958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Opportunistic Bilateral Salpingectomy vs Tubal Occlusion or Ligation for Ovarian Cancer Prophylaxis.
    Ely LK; Truong M
    J Minim Invasive Gynecol; 2017; 24(3):371-378. PubMed ID: 28087480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost evaluation, quality of life and pelvic organ function of three approaches to hysterectomy for benign uterine conditions: study protocol for a randomized controlled trial.
    Ekanayake C; Pathmeswaran A; Kularatna S; Herath R; Wijesinghe P
    Trials; 2017 Nov; 18(1):565. PubMed ID: 29178955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current surgical practice of prophylactic and opportunistic salpingectomy in France].
    Chene G; de Rochambeau B; Le Bail-Carval K; Beaufils E; Chabert P; Mellier G; Lamblin G
    Gynecol Obstet Fertil; 2016; 44(7-8):377-84. PubMed ID: 27363615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opportunistic salpingectomy during postpartum contraception procedures at elective and unscheduled cesarean delivery.
    Ferrari F; Forte S; Prefumo F; Sartori E; Odicino F
    Contraception; 2019 Jun; 99(6):373-376. PubMed ID: 30898658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menopausal symptoms and surgical complications after opportunistic bilateral salpingectomy, a register-based cohort study.
    Collins E; Strandell A; Granåsen G; Idahl A
    Am J Obstet Gynecol; 2019 Jan; 220(1):85.e1-85.e10. PubMed ID: 30321526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas.
    Rutstein SE; Siedhoff MT; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL; Wheeler SB
    J Minim Invasive Gynecol; 2016 Feb; 23(2):223-33. PubMed ID: 26475764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of opportunistic salpingectomy on anti-Müllerian hormone in patients undergoing laparoscopic hysterectomy: a multicentre randomised controlled trial.
    Song T; Kim MK; Kim ML; Jung YW; Yun BS; Seong SJ; Kwon SH
    BJOG; 2017 Jan; 124(2):314-320. PubMed ID: 27342222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.
    McAlpine JN; Hanley GE; Woo MM; Tone AA; Rozenberg N; Swenerton KD; Gilks CB; Finlayson SJ; Huntsman DG; Miller DM;
    Am J Obstet Gynecol; 2014 May; 210(5):471.e1-11. PubMed ID: 24412119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opportunistic salpingectomy for ovarian cancer prevention.
    Hanley GE; McAlpine JN; Kwon JS; Mitchell G
    Gynecol Oncol Res Pract; 2015; 2():5. PubMed ID: 27231565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opportunistic salpingectomy between 2011 and 2016: a descriptive analysis.
    Hanley GE; Niu J; Han J; Fung S; Bryant H; Kwon JS; Huntsman DG; Finlayson SJ; McAlpine JN; Miller D; Earle CC
    CMAJ Open; 2022; 10(2):E466-E475. PubMed ID: 35640988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers.
    Havrilesky LJ; Moss HA; Chino J; Myers ER; Kauff ND
    Gynecol Oncol; 2017 Jun; 145(3):549-554. PubMed ID: 28390820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States.
    Karia PS; Huang Y; Tehranifar P; Visvanathan K; Wright JD; Genkinger JM
    Am J Obstet Gynecol; 2022 Aug; 227(2):257.e1-257.e22. PubMed ID: 35489439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian cancer risk after salpingectomy: a nationwide population-based study.
    Falconer H; Yin L; Grönberg H; Altman D
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25628372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.